MedPath

A comparative study between hyperbaric ropivacaine and isobaric ropivacaine foe spinal anesthesia

Phase 4
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2023/11/060226
Lead Sponsor
Dr Sunil Chiruvella
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ASA 1 & 2

Exclusion Criteria

Patient refusal

Allergic to local anaesthetics

Pregnancy

Absolute contraindications for Regional anesthesia

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary objective is to compare onset and duration of sensory and motor blockadeTimepoint: 5 mins <br/ ><br>10 mins <br/ ><br>15 mins <br/ ><br>30 mins <br/ ><br>1 hour <br/ ><br>2 hours <br/ ><br>6 hours <br/ ><br>12 hours <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Secondary objective is to compare hemodynamic changes, intraoperative analgesia requirement and adverse effects in both groupsTimepoint: 5 mins <br/ ><br>10 mins <br/ ><br>15 mins <br/ ><br>30 mins <br/ ><br>1 hour <br/ ><br>2 hours <br/ ><br>6 hours <br/ ><br>12 hours <br/ ><br>
© Copyright 2025. All Rights Reserved by MedPath